Estrella Immunopharma, Inc. (ESLA) vs MARKER THERAPEUTICS, INC. (MRKR)
Estrella Immunopharma, Inc. and MARKER THERAPEUTICS, INC. are both Biotechnology companies. Estrella Immunopharma, Inc. and MARKER THERAPEUTICS, INC. are of similar size ($20.5M and $19.8M). Across the 9 metrics below, Estrella Immunopharma, Inc. leads on 5 and MARKER THERAPEUTICS, INC. on 4.
Valuation
Profitability
| Metric | ESLA | MRKR | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 148.05% | (76.87%) | (57.72%) |
| Return on assets | (416.74%) | (59.33%) | (49.22%) |
| Return on invested capital | 0.00% | (566.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack